PACAP-38 and Neuronal Differentiation in SH-SY5Y Cells
Author Information
Author(s): Monaghan T K, MacKenzie C J, Plevin R, Lutz E M
Primary Institution: Strathclyde Institute of Pharmacy and Biomedical Sciences, Royal College Glasgow, UK
Hypothesis
PACAP-38 induces neuronal differentiation of human SH-SY5Y neuroblastoma cells via cAMP-mediated activation of ERK and p38 MAP kinases.
Conclusion
PACAP-38 promotes neuronal differentiation in SH-SY5Y cells through a cAMP-dependent mechanism involving ERK and p38 MAP kinase activation.
Supporting Evidence
- PACAP-38 caused a concentration-dependent increase in the number of neurite-bearing cells.
- The expression of neuronal proteins Bcl-2 and GAP-43 was up-regulated by PACAP-38 treatment.
- PACAP-induced differentiation was blocked by the PAC1 receptor antagonist, PACAP6-38.
- Activation of ERK and p38 MAP kinase was stimulated by PACAP-38.
Takeaway
When a special protein called PACAP-38 is added to certain brain cells, it helps them grow and change into more mature nerve cells.
Methodology
The study involved treating SH-SY5Y cells with PACAP-38 and measuring changes in cell morphology and expression of neuronal markers.
Limitations
The study primarily focused on a single cell line and may not fully represent in vivo conditions.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website